Your browser doesn't support javascript.
loading
Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
Murray, Louise; Mason, Joshua; Henry, Ann M; Hoskin, Peter; Siebert, Frank-Andre; Venselaar, Jack; Bownes, Peter.
Afiliação
  • Murray L; Departments of Radiotherapy and Medical Physics, St James's Institute of Oncology, UK; University of Leeds, UK.
  • Mason J; Departments of Radiotherapy and Medical Physics, St James's Institute of Oncology, UK.
  • Henry AM; Departments of Radiotherapy and Medical Physics, St James's Institute of Oncology, UK; University of Leeds, UK. Electronic address: a.henry@leeds.ac.uk.
  • Hoskin P; Mount Vernon Cancer Centre, Northwood, UK.
  • Siebert FA; Klinik fur Strahlentherapie, Kiel, Germany.
  • Venselaar J; Institute Verbeeten, Tilburg, Netherlands.
  • Bownes P; Departments of Radiotherapy and Medical Physics, St James's Institute of Oncology, UK.
Radiother Oncol ; 120(2): 293-9, 2016 08.
Article em En | MEDLINE | ID: mdl-27370205

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Retais / Neoplasias da Bexiga Urinária / Braquiterapia / Segunda Neoplasia Primária / Modelos Biológicos / Neoplasias Induzidas por Radiação Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Retais / Neoplasias da Bexiga Urinária / Braquiterapia / Segunda Neoplasia Primária / Modelos Biológicos / Neoplasias Induzidas por Radiação Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article